Bicalutamide 150 Accord 150 mg Film coated tablet
PDF Leaflet Revision Date: 22 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of locally advanced prostate cancer.
Dosage (summary)
1 tablet (150 mg) once daily for 2 years or until progression.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Coumarin anticoagulants
Contraindications
- Females
- Children
- Hypersensitivity to bicalutamide
Common side effects
- Anaemia
- Dizziness
- Decreased libido
- Hot flush
- Hepatotoxicity
Counselling Points
- Avoid sun exposure
- Monitor liver function
- Use contraception during treatment
Serious warnings
- Severe hepatic changes
- QT prolongation risk
Important Disclaimer
The Bicalutamide 150 Accord 150 mg Film coated tablet professional information leaflet below is the property of Accord Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
